NGF Protein

NGF Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NGF Protein</th>
</tr>
<tr>
<td class="label">Stimulus</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Activity</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Injury</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Aging</td>
<td>Decreased</td>
</tr>
<tr>
<td class="label">[Aβ](/proteins/amyloid-beta)</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Target [Neurons](/entities/neurons)</td>
</tr>
<tr>
<td class="label">Survival</td>
<td>Sympathetic, sensory</td>
</tr>
<tr>
<td class="label">Differentiation</td>
<td>Neural crest-derived</td>
</tr>
<tr>
<td class="label">Maintenance</td>
<td>Basal forebrain cholinergic</td>
</tr>
<tr>
<td class="label">Plasticity</td>
<td>Hippocampal neurons</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">Recombinant protein</td>
<td>Mature NGF</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-NGF</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>TrkA agonists</td>
</tr>
<tr>
<td class="label">Anti-NGF antibodies</td>
<td>Tanezumab</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color

...

NGF Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NGF Protein</th>
</tr>
<tr>
<td class="label">Stimulus</td>
<td>Effect</td>
</tr>
<tr>
<td class="label">Activity</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Injury</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Aging</td>
<td>Decreased</td>
</tr>
<tr>
<td class="label">[Aβ](/proteins/amyloid-beta)</td>
<td>Increased</td>
</tr>
<tr>
<td class="label">Function</td>
<td>Target [Neurons](/entities/neurons)</td>
</tr>
<tr>
<td class="label">Survival</td>
<td>Sympathetic, sensory</td>
</tr>
<tr>
<td class="label">Differentiation</td>
<td>Neural crest-derived</td>
</tr>
<tr>
<td class="label">Maintenance</td>
<td>Basal forebrain cholinergic</td>
</tr>
<tr>
<td class="label">Plasticity</td>
<td>Hippocampal neurons</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Agent</td>
</tr>
<tr>
<td class="label">Recombinant protein</td>
<td>Mature NGF</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-NGF</td>
</tr>
<tr>
<td class="label">Small molecules</td>
<td>TrkA agonists</td>
</tr>
<tr>
<td class="label">Anti-NGF antibodies</td>
<td>Tanezumab</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">247 edges</a></td>
</tr>
</table>

Introduction

Ngf Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Nerve Growth Factor (NGF) is the founding member of the neurotrophin family, first discovered by Rita Levi-Montalcini and Stanley Cohen in the 1950s. NGF is a critical protein that supports the survival, development, and function of specific neuronal populations in the peripheral and central nervous systems.

NGF binds to two distinct classes of receptors: TrkA (tropomyosin receptor kinase A) with high affinity and p75NTR (p75 neurotrophin receptor) with lower affinity. This dual receptor system enables nuanced responses to NGF signaling, including survival, differentiation, and apoptosis depending on cellular context.

Gene and Protein Structure

The NGF gene (NGF) is located on chromosome 1p13.1 and consists of 3 exons spanning approximately 45 kb. The protein is synthesized as a 140 kDa precursor (pro-NGF) that is proteolytically cleaved to generate the mature 26 kDa homodimer.

Protein Structure

NGF belongs to the neurotrophin family and shares structural homology with BDNF, NT-3, and NT-4. The mature protein:

• Length: 120 amino acids per monomer
• Structure: Cysteine knot fold with three disulfide bonds
• Dimerization: Forms stable homodimers
• Molecular weight: ~13 kDa per monomer, ~26 kDa active dimer

Processing

NGF is synthesized as a pre-pro-protein:

Pre-sequence: 18 aa signal peptide for secretion

Pro-domain: 103 aa propeptide (may have independent functions)

Mature domain: 120 aa C-terminal growth factor domain

Expression Pattern

Peripheral Nervous System

NGF is expressed in:

• Target tissues: Skin, smooth muscle, salivary gland
• Immune cells: Macrophages, mast cells
• Schwann cells: Peripheral glia

Central Nervous System

• Basal forebrain: Cholinergic neuron targets
• [Hippocampus](/brain-regions/hippocampus): Pyramidal neurons
• [Cortex](/brain-regions/cortex): Layer 5 pyramidal neurons
• Thalamus: Relay neurons

Regulation

NGF expression is dynamically regulated:

Molecular Function

Receptor Binding

TrkA Signaling

High-affinity binding to TrkA triggers:

Receptor dimerization: Induces conformational change

Autophosphorylation: Activation of kinase domain

Downstream cascades:

• PI3K/Akt pathway (survival)
• MAPK/ERK pathway (differentiation)
• PLCγ pathway (plasticity)

p75NTR Signaling

When co-expressed with TrkA:

• Enhanced TrkA signaling: Increased ligand affinity
• Survival signaling: Through [NF-κB](/entities/nf-kb) and Akt

When expressed alone:

• [Apoptosis](/entities/apoptosis): Through JNK cascade
• Cell death: In absence of TrkA ligands

Biological Functions

Role in Neurodegeneration

Alzheimer's Disease

NGF plays complex roles in AD:

• Basal forebrain degeneration: Loss of cholinergic neurons
• NGF therapy attempts: Intracerebral NGF delivery trials
• Pro-NGF accumulation: Increased in AD brain
• TrkA dysfunction: Reduced signaling in AD

Parkinson's Disease

In PD:

• Dopaminergic neurons: NGF supports survival
• Combination therapy: NGF with other neurotrophins
• Gene therapy approaches: AAV-NGF delivery

Peripheral Neuropathy

NGF is critical for:

• Small fiber neuropathy: NGF deficiency
• Diabetic neuropathy: Reduced NGF levels
• Chemotherapy-induced: Treatment-related loss
• Therapeutic use: Recombinant NGF (mebetaserod)

Chronic Pain

Paradoxically, NGF:

• Promotes pain: Increases nociceptor sensitization
• Anti-NGF antibodies: Tanezumab for chronic pain
• Contradictory roles: Context-dependent effects

Therapeutic Implications

Clinical Applications

Challenges

• [Blood-brain barrier](/entities/blood-brain-barrier): NGF does not cross
• Side effects: Pain and hyperalgesia
• Delivery: Requires direct CNS administration
• Dosage: Narrow therapeutic window

Animal Models

Knockout Studies

• Ng KO mice: Die postnatally
• TrkA KO: Similar phenotype
• Conditional KO: Region-specific deletion

Disease Models

• AD models: NGF supplementation improves cognition
• PD models: NGF protects dopaminergic neurons
• Age models: NGF restores youthful plasticity

Research Directions

Novel delivery: Nanoparticles, intranasal approaches

Engineered variants: Modified NGF with improved properties

Biomarkers: NGF levels as therapeutic marker

Combination therapy: NGF with other neurotrophins

Background

The study of Ngf Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[1]: https://pubmed.ncbi.nlm.nih.gov/10629201/ PMID: 10629201(https://pubmed.ncbi.nlm.nih.gov/10629201/)
[2]: https://pubmed.ncbi.nlm.nih.gov/10816402/ PMID: 10816402(https://pubmed.ncbi.nlm.nih.gov/10816402/)
[3]: https://pubmed.ncbi.nlm.nih.gov/15604288/ PMID: 15604288(https://pubmed.ncbi.nlm.nih.gov/15604288/)
[4]: https://pubmed.ncbi.nlm.nih.gov/17585956/ PMID: 17585956(https://pubmed.ncbi.nlm.nih.gov/17585956/)
[5]: https://pubmed.ncbi.nlm.nih.gov/19029120/ PMID: 19029120(https://pubmed.ncbi.nlm.nih.gov/19029120/)
[6]: https://pubmed.ncbi.nlm.nih.gov/21844166/ PMID: 21844166(https://pubmed.ncbi.nlm.nih.gov/21844166/)
[7]: https://pubmed.ncbi.nlm.nih.gov/25449608/ PMID: 25449608(https://pubmed.ncbi.nlm.nih.gov/25449608/)
[8]: https://pubmed.ncbi.nlm.nih.gov/28968456/ PMID: 28968456(https://pubmed.ncbi.nlm.nih.gov/28968456/)

See Also

• NGF Gene
• [TrkA Protein](/proteins/trka-protein)
• [Neurotrophic Factors](/therapeutics/neurotrophic-factor-therapies)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Basal Forebrain Cholinergic Neurons](/cell-types/basal-forebrain-cholinergic-neurons)

External Links

• [UniProt: NGF](https://www.uniprot.org/uniprot/P01138)
• [PDB: NGF](https://www.rcsb.org/structure/1BET)
• [GeneCards: NGF](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NGF)
• [NCBI Gene: NGF](https://www.ncbi.nlm.nih.gov/gene/4800)